LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 17

Search options

  1. Conference proceedings: Digitale Gesundheitsanwendungen als Bestandteil des Leistungskataloges der GKV (DIGA): Erfahrungen zu den ersten erstattungsfähigen Produkten sowie dem zugehörigen Nachweis eines positiven Versorgungseffekts

    Hagenmeyer, Ernst-Günther

    2021  , Page(s) 21ebmPS–2–09

    Event/congress 22. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; Who cares? – EbM und Transformation im Gesundheitswesen; sine loco [digital]; Deutsches Netzwerk Evidenzbasierte Medizin e.V.; 2021
    Keywords Medizin, Gesundheit
    Publishing date 2021-02-23
    Publisher German Medical Science GMS Publishing House; Düsseldorf
    Document type Conference proceedings
    DOI 10.3205/21ebm063
    Database German Medical Science

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Book: Weissbuch Diabetes in Deutschland

    Häussler, Bertram / Klein, Silvia / Hagenmeyer, Ernst-Günther

    Bestandsaufnahme und Zukunftsperspektiven ; 20 Tabellen

    2010  

    Author's details Bertram Häussler ; Silvia Klein ; Ernst-Günther Hagenmeyer
    Keywords Deutschland ; Diabetes mellitus ; Medizinische Versorgung
    Subject Gesundheitsversorgung ; Gesundheitliche Versorgung ; Patientenversorgung ; Diabetes verus ; Zuckerharnruhr ; Zuckerkrankheit
    Language German
    Size XII, 107 S. : Ill., 240 mm x 170 mm
    Edition 2., vollst. überarb. Aufl.
    Publisher Thieme
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    HBZ-ID HT016312043
    ISBN 978-3-13-143702-0 ; 3-13-143702-2
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2010 A 3388 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Book: Schlaganfallerkrankung, ökonomische Evaluation und Markov-Modell

    Hagenmeyer, Ernst-Günther

    Kosten-Nutzen-Vergleich von Normalstation- und Stroke-Unit-Behandlung im deutschen Gesundheitswesen

    (Schriftenreihe Gesundheit, Pflege, soziale Arbeit ; 7)

    2000  

    Author's details Ernst-Günther Hagenmeyer
    Series title Schriftenreihe Gesundheit, Pflege, soziale Arbeit ; 7
    Schriftenreihe Gesundheit - Pflege - soziale Arbeit
    Collection Schriftenreihe Gesundheit - Pflege - soziale Arbeit
    Keywords Deutschland ; Schlaganfall ; Frühdiagnostik ; Frührehabilitation ; Kosten-Nutzen-Analyse ; Evaluation
    Subject Evaluierung ; Cost-benefit-Analyse ; Cost-benefit analysis ; Nutzen-Kosten-Analyse ; Kostennutzenanalyse ; Nutzenkostenanalyse ; Früherkennung ; Frühdiagnose ; Apoplektischer Insult ; Apoplexia cerebri ; Apoplexie ; Gehirnschlag ; Hirnschlag ; Zerebrovaskulärer Insult ; ZVI ; Ischämischer Insult ; Stroke
    Language German
    Size 141 S. : graph. Darst.
    Publisher Jacobs
    Publishing place Lage
    Publishing country Germany
    Document type Book
    HBZ-ID HT012821159
    ISBN 3-932136-51-9 ; 978-3-932136-51-1
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2001 A 3143 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Conference proceedings: Bewertung von mHealth-Apps: aktuelle Praxis in europäischen Ländern und Nordamerika

    Hagenmeyer, Ernst-Günther

    2019  , Page(s) 19ebmS3–V5–05

    Event/congress 20. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; EbM und Digitale Transformation in der Medizin; Berlin; Deutsches Netzwerk Evidenzbasierte Medizin e.V.; 2019
    Keywords Medizin, Gesundheit
    Publishing date 2019-03-20
    Publisher German Medical Science GMS Publishing House; Düsseldorf
    Document type Conference proceedings
    DOI 10.3205/19ebm025
    Database German Medical Science

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article ; Online: Das neue Bewertungsverfahren zur Erstattung digitaler Gesundheitsanwendungen (DiGA) aus Sicht der gesetzlichen Krankenversicherung.

    Gregor-Haack, Johanna / Busse, Thorsten / Hagenmeyer, Ernst-Günther

    Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

    2021  Volume 64, Issue 10, Page(s) 1220–1227

    Abstract: Since fall of 2020, the first Digital Health Applications (DiGA) have been available as a service of the statutory health insurance. The National Association of Statutory Health Insurance Funds considers digital applications to have the potential to ... ...

    Title translation The new approval process for the reimbursement of digital health applications (DiGA) from the perspective of the German statutory health insurance.
    Abstract Since fall of 2020, the first Digital Health Applications (DiGA) have been available as a service of the statutory health insurance. The National Association of Statutory Health Insurance Funds considers digital applications to have the potential to improve health care, e.g., for people with chronic diseases, and to consolidate the interconnectedness of the provided offers. DiGA can empower the insured persons to help shape their health care actively and to self-contribute to a successful treatment. At the same time, statutory health insurance identifies a number of basic and substantial critical issues regarding the legal requirements for the authorization of DiGA for reimbursement by insurance and the conceptional design of the fast-track process from the Federal Institute for Drugs and Medical Devices (BfArM).This article examines the DiGA, which have been listed in the BfArM directory up to this point, and takes stock after six months of the fast-track process being in place. According to this, the requirements and legal specifications for directory listings and reimbursement via the fast-track process are insufficient from the point of view of the statutory health insurance regarding proven medical effectiveness and economically efficient health care. At present, most of the authorized DiGA, which so far could not provide sufficient evidence about positive healthcare effects, are subsequently only listed provisionally. At the same time, the requirements for proof of medical benefit do not ensure the generation of valid results in studies or clinical trials with regards to routine everyday care. So far, there has been only a moderate qualitative reliability of results. Furthermore, in the context of free pricing by manufacturers, significant price increases can be observed in some cases compared to prices before the BfArM listing.This paper gives recommendations towards further development of the legal basis for the fast-track process, particularly in the subject areas of benefit and patient safety as well as cost effectiveness.
    MeSH term(s) Cost-Benefit Analysis ; Germany ; Humans ; Insurance, Health ; National Health Programs ; Reproducibility of Results
    Language German
    Publishing date 2021-08-30
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1461973-8
    ISSN 1437-1588 ; 1436-9990
    ISSN (online) 1437-1588
    ISSN 1436-9990
    DOI 10.1007/s00103-021-03401-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Un I Zs.525: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Book ; Thesis: Vergleich des Hörens über Luft- und Knochenleitung im Gehörtest nach dem Kategorienunterteilungsverfahren

    Hagenmeyer, Ernst-Günther

    1993  

    Author's details vorgelegt von Ernst-Günther Hagenmeyer
    Language German
    Size III, 78 Bl. : graph. Darst.
    Edition [Mikrofiche-Ausg.]
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Würzburg, Univ., Diss., 1995
    Note Mikrofiche-Ausg.: 1 Mikrofiche : 24x
    HBZ-ID HT007178021
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    1996 MB 1498 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article ; Online: DO STUDY RESULTS TRANSLATE INTO PRACTICE? INTRACRANIAL STENTING IN GERMANY.

    Schillinger, Gerhard / Hagenmeyer, Ernst-Günther / Pritzkau, Andreas / Friedrich, Jörg

    International journal of technology assessment in health care

    2017  Volume 33, Issue 2, Page(s) 222–226

    Abstract: Objectives: Enrolment into the SAMMPRIS trial published in September 2011 had to be stopped due to a 2.5 higher 30-day stroke and death rate in patients with percutaneous transluminal angioplasty and stenting (PTAS) compared with the control group with ... ...

    Abstract Objectives: Enrolment into the SAMMPRIS trial published in September 2011 had to be stopped due to a 2.5 higher 30-day stroke and death rate in patients with percutaneous transluminal angioplasty and stenting (PTAS) compared with the control group with only medical therapy. After these results were published, one would have expected a change toward a clearer definition of indications for intracranial stent implantation in patients with intracranial artery stenosis, using this treatment only in patients suffering from recurrent strokes despite aggressive medical management.
    Methods: The frequency of intracranial stenting and indication parameters in patients with intracranial artery stenosis were assessed from 2010 to 2013 using claims data for all inpatient episodes from Germany's largest provider of statutory health insurance.
    Results: The number of intracranial stenting procedures decreased slowly from 580 in 2010 to 375 in 2013. With a rate of 29 percent there was no change between 2010 and 2013 of patients who were admitted to hospital for stent implantation, without documentation of an acute stroke or transient ischemic attack (TIA). Before PTAS, one-third of patients were admitted twice because of a stroke or TIA over a period of 5 years, 17 percent of patients had been prescribed platelet aggregation inhibitors and at least two admissions to hospital were for an ischemic cerebrovascular event before PTAS.
    Conclusions: Our analysis of German claims data provides little evidence of changed indications for stenting in cases of intracranial atherosclerotic disease which one might expect to be caused by the emergence of high-level evidence.
    Language English
    Publishing date 2017-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 632573-7
    ISSN 1471-6348 ; 0266-4623
    ISSN (online) 1471-6348
    ISSN 0266-4623
    DOI 10.1017/S0266462317000411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 2073: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Stufendiagnostik nach der Richtlinie des G-BA und Versorgungswirklichkeit bei vermuteter Schlafapnoe – eine Analyse basierend auf Routinedaten der Techniker Krankenkasse.

    Schneider, Udo / Linder, Roland / Hagenmeyer, Ernst-Günther / Storz-Pfennig, Philipp / Verheyen, Frank

    Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

    2017  Volume 79, Issue 1, Page(s) 42–47

    Abstract: In 2004, the Federal Joint Committee (G-BA) published a new directive for examination and treatment methods with respect to sleep-related breathing disorders for SHI-accredited physicians. The examination procedure is classified in four steps: anamnesis, ...

    Title translation Stepwise Diagnostics, Federal Joint Committee Directive and Actual Care in the Case of Sleep-related Breathing Disorders - An Analysis Based on Claims Data of the Techniker Krankenkasse.
    Abstract In 2004, the Federal Joint Committee (G-BA) published a new directive for examination and treatment methods with respect to sleep-related breathing disorders for SHI-accredited physicians. The examination procedure is classified in four steps: anamnesis, clinical assessment, cardiorespiratory polygraphy (PG) and cardiorespiratory polysomnography (PSG). Starting with the date of the first PSG we analysed 1. whether this examination was preceded by a polygraphy, 2. whether there was a gain of diagnostic information through PSG, and 3. whether a PSG was used for the first adjustment examinations and controls after prescription of a positive airway pressure device. The analysis is based on claims data from the Techniker Krankenkasse (2009-2012). Diagnostic services were identified by fee schedule codes (EBM) for outpatient services and by procedure codes (OPS) for inpatient services. Sleep disorders were operationalised by ICD-10 codes and information was completed by prescriptions of a CPAP equipment.The study is based on data from 6.6 million persons who were permanently insured from 01.01.2009 to 30.06.2012 by TK. A preceding PG 90 (180) days before PSG was found for less than 56% (73%) of the analysed insured persons. By the latter procedure, only about 60% of the cases with no clear diagnostic information (G47.39) in the preceding quarter could be specified. Prescription of a positive airway pressure device within 90 days after PSG was found for about 45% of the insured. Concerning the stepwise diagnostic procedure for sleep disorders for SHI-accredited physicians, the directive was followed only partly. Against the background of an evidence-based, effective, and efficient diagnostic approach, the results show a clear need for action.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Female ; Germany/epidemiology ; Humans ; Insurance Claim Reporting/statistics & numerical data ; Male ; Middle Aged ; Polysomnography/utilization ; Positive-Pressure Respiration/utilization ; Practice Patterns, Physicians'/statistics & numerical data ; Prevalence ; Sleep Apnea Syndromes/diagnosis ; Sleep Apnea Syndromes/epidemiology ; Sleep Apnea Syndromes/therapy ; Treatment Outcome ; Utilization Review
    Language German
    Publishing date 2017-01
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1101426-x
    ISSN 1439-4421 ; 0941-3790 ; 0949-7013
    ISSN (online) 1439-4421
    ISSN 0941-3790 ; 0949-7013
    DOI 10.1055/s-0035-1549987
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Un I Zs.402: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review.

    Hagenmeyer, Ernst-Günther / Koltermann, Katharina C / Dippel, Franz-Werner / Schädlich, Peter K

    Cost effectiveness and resource allocation : C/E

    2011  Volume 9, Issue 1, Page(s) 15

    Abstract: Background: Compared to conventional human basal insulin (neutral protamine Hagedorn; NPH) the long-acting analogue insulin glargine (GLA) is associated with a number of advantages regarding metabolic control, hypoglycaemic events and convenience. ... ...

    Abstract Background: Compared to conventional human basal insulin (neutral protamine Hagedorn; NPH) the long-acting analogue insulin glargine (GLA) is associated with a number of advantages regarding metabolic control, hypoglycaemic events and convenience. However, the unit costs of GLA exceed those of NPH. This study aims to systematically review the economic evidence comparing GLA with NPH in basal-bolus treatment (intensified conventional therapy; ICT) of type 1 diabetes in order to facilitate informed decision making in clinical practice and health policy.
    Methods: A systematic literature search was performed for the period of January 1st 2000 to December 1st 2009 via Embase, Medline, the Cochrane Library, the databases GMS (German Medical Science) and DAHTA (Deutsche Agentur für Health Technology Assessment), and the abstract books of relevant international scientific congresses. Retrieved studies were reviewed based on predefined inclusion criteria, methodological and quality aspects. In order to allow comparison between studies, currencies were converted using purchasing power parities (PPP).
    Results: A total of 7 health economic evaluations from 4 different countries fulfilled the predefined criteria: 6 modelling studies, all of them cost-utility analyses, and one claims data analysis with a cost-minimisation design. One cost-utility analysis showed dominance of GLA over NPH. The other 5 cost-utility analyses resulted in additional costs per quality adjusted life year (QALY) gained for GLA, ranging from € 3,859 to € 57,002 (incremental cost effectiveness ratio; ICER). The cost-minimisation analysis revealed lower annual diabetes-specific costs in favour of NPH from the perspective of the German Statutory Health Insurance (SHI).
    Conclusions: The incremental cost-utility-ratios (ICER) show favourable values for GLA with considerable variation. If a willingness-to-pay threshold of £ 30,000 (National Institute of Clinical Excellence, UK) is adopted, GLA is cost-effective in 4 of 6 cost utility analyses (CUA) included. Thus insulin glargine (GLA) seems to offer good value for money. Comparability between studies is limited because of methodological and country specific aspects. The results of this review underline that evaluation of insulin therapy should use evidence on efficacy of therapy from information synthesis. The concept of relating utility decrements to fear of hypoglycaemia is a plausible approach but needs further investigation. Also future evaluations of basal-bolus insulin therapy should include costs of consumables such as needles for insulin injection as well as test strips and lancets for blood glucose self monitoring.
    Language English
    Publishing date 2011-10-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2119372-1
    ISSN 1478-7547 ; 1478-7547
    ISSN (online) 1478-7547
    ISSN 1478-7547
    DOI 10.1186/1478-7547-9-15
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Book: Schlaganfallerkrankung, ökonomische Evaluation und Markov-Modell

    Hagenmeyer, Ernst-Günther

    Kosten-Nutzen-Vergleich von Normalstation- und Stroke-Unit -Behandlung im deutschen Gesundheitswesen

    (Schriftenreihe Gesundheit, Pflege, soziale Arbeit ; Bd. 7)

    2000  

    Author's details Ernst-Günther Hagenmeyer
    Series title Schriftenreihe Gesundheit, Pflege, soziale Arbeit ; Bd. 7
    MeSH term(s) Stroke/economics ; Cost-Benefit Analysis ; Markov Chains
    Keywords Germany
    Language German
    Size 141 p. :, ill.
    Publisher Verlag Hans Jacobs
    Publishing place Lage
    Document type Book
    ISBN 9783932136511 ; 3932136519
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top